OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Crosstalk between MiRNAs/lncRNAs and PI3K/AKT signaling pathway in diabetes mellitus: Mechanistic and therapeutic perspectives
Seyed Mohsen Aghaei Zarch
Non-coding RNA Research (2024) Vol. 9, Iss. 2, pp. 486-507
Open Access | Times Cited: 11

Showing 11 citing articles:

The microRNA Let-7 and its exosomal form: Epigenetic regulators of gynecological cancers
Fei Wang, Chundi Zhou, Yanping Zhu, et al.
Cell Biology and Toxicology (2024) Vol. 40, Iss. 1
Open Access | Times Cited: 5

Evaluation of circulating plasma miR-9, miR-29a, miR-192, and miR-375 as potential biomarkers for predicting prediabetes and type 2 diabetes in Nepali adult population
Daya Ram Pokharel, Abhishek Maskey, Ramchandra Kafle, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 4, pp. 1324-1332
Closed Access | Times Cited: 4

microRNAs in Type 1 Diabetes: Roles, Pathological Mechanisms, and Therapeutic Potential
H. Cho, Se Eun Ha, Rajan Singh, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3301-3301
Open Access

RNA-based diagnostic innovations: A new frontier in diabetes diagnosis and management
Esther Ugo Alum, Ernest Nnamdi Ikpozu, Christian Emeka Offor, et al.
Diabetes and Vascular Disease Research (2025) Vol. 22, Iss. 2
Open Access

Mechanistic and therapeutic perspectives of miRNA-PTEN signaling axis in cancer therapy resistance
Di Wu, Chunjie Huang, Kaifeng Guan
Biochemical Pharmacology (2024) Vol. 226, pp. 116406-116406
Closed Access | Times Cited: 3

Long non-coding RNA LOXL1-AS1: a potential biomarker and therapeutic target in human malignant tumors
Xiaoping Fu, Chunyan Ji, Wenqian Tang, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2

Gut microbiota–lncRNA/circRNA crosstalk: implications for different diseases
Lei Zhang, Xin Li, Huijuan Gao, et al.
Critical Reviews in Microbiology (2024), pp. 1-15
Closed Access | Times Cited: 2

The scaffold protein disabled 2 (DAB2) and its role in tumor development and progression
Disha V. Pandya, Rajsi V. Parikh, Ruhanahmed M. Gena, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 1

MCM4 Promotes the Progression of Malignant Melanoma by Activating the PI3K/AKT Pathway
Xuewei Zhang, Mingming Dong, Guoxing Zheng, et al.
Environmental Toxicology (2024) Vol. 40, Iss. 2, pp. 306-317
Closed Access

Mesenchymal stem cell-derived extracellular vesicles: A promising therapeutic strategy in diabetic osteoporosis
Yajing Yang, Xi-Er Chen, Xuchang Zhou, et al.
World Journal of Diabetes (2024) Vol. 15, Iss. 12, pp. 2399-2403
Closed Access

Page 1

Scroll to top